Genetronics Biomedical Ltd. has filed a preliminary short-form prospectus for a public offering with Canadian securities regulators. The San Diego-based biotechnology firm, whose shares are listed on the Toronto Stock Exchange, said it will use the funds raised through an offering to start a gene-therapy project and to develop the company's oncology business in Canada.
- Report on Business Company Snapshot is available for:
- GENETRONICS BIOMEDICAL LTD.